Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1751 - 11
Accumulating evidence suggests that exogenous cellular stress induces PD-L1 upregulation in cancer. A DNA double-strand break (DSB) is the most critical type...
TUMOR-INFILTRATING LYMPHOCYTES | LUNG-CANCER | IMMUNE-SYSTEM | BRAF MUTATION | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | NUCLEASE ACTIVITIES | NEOANTIGEN LOAD | HOMOLOGOUS RECOMBINATION | T-CELLS | ATR-DEPENDENT PHOSPHORYLATION | Neoplasms - metabolism | Ataxia Telangiectasia Mutated Proteins - metabolism | Humans | B7-H1 Antigen - genetics | DNA Breaks, Double-Stranded | Checkpoint Kinase 1 - metabolism | B7-H1 Antigen - metabolism | BRCA2 Protein - metabolism | Neoplasms - genetics | DNA Repair | Cell Line, Tumor | Ataxia Telangiectasia Mutated Proteins - genetics | BRCA2 Protein - genetics | Checkpoint Kinase 1 - genetics | DNA damage | Genotoxicity | Interferon regulatory factor 1 | Kinases | DNA repair | Signal transduction | Exonuclease | Ionizing radiation | Stat1 protein | Repair | Deoxyribonucleic acid--DNA | BRCA2 protein | CHK1 protein | Stat3 protein | Poly(ADP-ribose) polymerase | Breast cancer | siRNA | Double-strand break repair | Gene expression | Signaling | X rays | Depletion | PD-L1 protein | Genetic recombination | Cellular stress response | Cancer
TUMOR-INFILTRATING LYMPHOCYTES | LUNG-CANCER | IMMUNE-SYSTEM | BRAF MUTATION | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | NUCLEASE ACTIVITIES | NEOANTIGEN LOAD | HOMOLOGOUS RECOMBINATION | T-CELLS | ATR-DEPENDENT PHOSPHORYLATION | Neoplasms - metabolism | Ataxia Telangiectasia Mutated Proteins - metabolism | Humans | B7-H1 Antigen - genetics | DNA Breaks, Double-Stranded | Checkpoint Kinase 1 - metabolism | B7-H1 Antigen - metabolism | BRCA2 Protein - metabolism | Neoplasms - genetics | DNA Repair | Cell Line, Tumor | Ataxia Telangiectasia Mutated Proteins - genetics | BRCA2 Protein - genetics | Checkpoint Kinase 1 - genetics | DNA damage | Genotoxicity | Interferon regulatory factor 1 | Kinases | DNA repair | Signal transduction | Exonuclease | Ionizing radiation | Stat1 protein | Repair | Deoxyribonucleic acid--DNA | BRCA2 protein | CHK1 protein | Stat3 protein | Poly(ADP-ribose) polymerase | Breast cancer | siRNA | Double-strand break repair | Gene expression | Signaling | X rays | Depletion | PD-L1 protein | Genetic recombination | Cellular stress response | Cancer
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5634 - 5634
Abstract Background Multiple myeloma shows various morphological abnormalities such as plasmablastic morphology, cytoplasmic granules, vacuolation, and nuclear...
Journal Article
Oncogene, ISSN 0950-9232, 02/2019, Volume 38, Issue 23, pp. 4452 - 4466
Programmed death-ligand 1 (PD-L1) is a key factor influencing cancer immunotherapy; however, the regulation of PD-L1 expression in cancer cells remains...
Oxidative stress | Hydrogen peroxide | CHK1 protein | DNA damage | Genomes | DNA glycosylase | Microsatellite instability | Gene expression | Kinases | DNA repair | Base excision repair | Signal transduction | Immunotherapy | γ-Interferon | PD-L1 protein | Deoxyribonucleic acid--DNA | Cancer | Apoptosis | Tumors
Oxidative stress | Hydrogen peroxide | CHK1 protein | DNA damage | Genomes | DNA glycosylase | Microsatellite instability | Gene expression | Kinases | DNA repair | Base excision repair | Signal transduction | Immunotherapy | γ-Interferon | PD-L1 protein | Deoxyribonucleic acid--DNA | Cancer | Apoptosis | Tumors
Journal Article
Cell Reports, ISSN 2211-1247, 01/2017, Volume 18, Issue 2, pp. 520 - 532
BRCA1 promotes homologous recombination (HR) by activating DNA-end resection. By contrast, 53BP1 forms a barrier that inhibits DNA-end resection. Here, we show...
RIF1 | 53BP1 | ATM | DNA-end resection | PP4C | BRCA1 | NHEJ | CHOICE | RECRUITMENT | MAINTENANCE | DNA END RESECTION | STRAND BREAK REPAIR | REPLICATION | PP4 | NUCLEASE ACTIVITIES | IONIZING-RADIATION | CELL BIOLOGY | Phosphorylation | Ataxia Telangiectasia Mutated Proteins - metabolism | Signal Transduction | Humans | Phosphoprotein Phosphatases - metabolism | Homologous Recombination | Nuclear Proteins - metabolism | DNA Breaks, Double-Stranded | Carrier Proteins - metabolism | BRCA1 Protein - metabolism | DNA Repair | S Phase | DNA Repair Enzymes - metabolism | Exodeoxyribonucleases - metabolism | G2 Phase | MRE11 Homologue Protein - metabolism | Telomere-Binding Proteins - metabolism | Tumor Suppressor p53-Binding Protein 1 - metabolism
RIF1 | 53BP1 | ATM | DNA-end resection | PP4C | BRCA1 | NHEJ | CHOICE | RECRUITMENT | MAINTENANCE | DNA END RESECTION | STRAND BREAK REPAIR | REPLICATION | PP4 | NUCLEASE ACTIVITIES | IONIZING-RADIATION | CELL BIOLOGY | Phosphorylation | Ataxia Telangiectasia Mutated Proteins - metabolism | Signal Transduction | Humans | Phosphoprotein Phosphatases - metabolism | Homologous Recombination | Nuclear Proteins - metabolism | DNA Breaks, Double-Stranded | Carrier Proteins - metabolism | BRCA1 Protein - metabolism | DNA Repair | S Phase | DNA Repair Enzymes - metabolism | Exodeoxyribonucleases - metabolism | G2 Phase | MRE11 Homologue Protein - metabolism | Telomere-Binding Proteins - metabolism | Tumor Suppressor p53-Binding Protein 1 - metabolism
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1998 - 11
Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) are genetically and phenotypically heterogeneous. Cardiac function is improved after...
Cardiomyopathy, Dilated - genetics | Cardiomyopathy, Dilated - pathology | Cardiomyopathy, Hypertrophic - genetics | Cardiac Myosins - genetics | Humans | Middle Aged | Connectin - genetics | Myosin Heavy Chains - genetics | Male | Carrier Proteins - genetics | Ventricular Remodeling | Lamin Type A - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Mutation | Heart Ventricles - pathology | Cardiomyopathy, Hypertrophic - pathology | Heart | Prognosis | Dilated cardiomyopathy | Cardiomyopathy | Whites | Ventricle | Heart diseases | Genotypes
Cardiomyopathy, Dilated - genetics | Cardiomyopathy, Dilated - pathology | Cardiomyopathy, Hypertrophic - genetics | Cardiac Myosins - genetics | Humans | Middle Aged | Connectin - genetics | Myosin Heavy Chains - genetics | Male | Carrier Proteins - genetics | Ventricular Remodeling | Lamin Type A - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Mutation | Heart Ventricles - pathology | Cardiomyopathy, Hypertrophic - pathology | Heart | Prognosis | Dilated cardiomyopathy | Cardiomyopathy | Whites | Ventricle | Heart diseases | Genotypes
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, p. e0122582
The choice of DNA double strand break (DSB) repair pathway is determined at the stage of DSB end resection. Resection was proposed to control the balance...
PATHWAY CHOICE | HUMAN-LYMPHOCYTES | GAMMA-H2AX FOCI | MULTIDISCIPLINARY SCIENCES | G2 PHASE | CELL-CYCLE | ATM | ADAPTIVE RESPONSE | G/M CHECKPOINT ARREST | DAMAGE | REVEALS | Phosphorylation | Recombinational DNA Repair | Humans | Cell Line, Tumor | Homologous Recombination | DNA Damage | Radiation, Ionizing | Proteins | Ionizing radiation | DNA repair | Surgery | DNA | Post-transcription | Laboratories | DNA damage | Homologous recombination | G2 phase | Homology | Genomes | Kinases | Cancer therapies | Homologous recombination repair | Cell cycle | Fibroblasts | Repair | Deoxyribonucleic acid--DNA | Incubation | Replication protein A | Exposure | Protein A | Gene expression | Double-strand break repair | Non-homologous end joining | Kinetics | Deoxyribonucleic acid
PATHWAY CHOICE | HUMAN-LYMPHOCYTES | GAMMA-H2AX FOCI | MULTIDISCIPLINARY SCIENCES | G2 PHASE | CELL-CYCLE | ATM | ADAPTIVE RESPONSE | G/M CHECKPOINT ARREST | DAMAGE | REVEALS | Phosphorylation | Recombinational DNA Repair | Humans | Cell Line, Tumor | Homologous Recombination | DNA Damage | Radiation, Ionizing | Proteins | Ionizing radiation | DNA repair | Surgery | DNA | Post-transcription | Laboratories | DNA damage | Homologous recombination | G2 phase | Homology | Genomes | Kinases | Cancer therapies | Homologous recombination repair | Cell cycle | Fibroblasts | Repair | Deoxyribonucleic acid--DNA | Incubation | Replication protein A | Exposure | Protein A | Gene expression | Double-strand break repair | Non-homologous end joining | Kinetics | Deoxyribonucleic acid
Journal Article
International Journal of Hematology, ISSN 0925-5710, 12/2016, Volume 104, Issue 6, pp. 669 - 681
Plasmablastic lymphoma (PBL) is a rare AIDS-related malignancy with a poor prognosis. Little is known about this entity, and no standard treatment regimen has...
CD4 | Medicine & Public Health | Hematology | Combination antiretroviral therapy | Acquired immunodeficiency syndrome | Oncology | Plasmablastic lymphoma | Human immunodeficiency virus | Epstein–Barr virus | ORAL-CAVITY | AIDS | BORTEZOMIB | COMBINATION | CANCER | CHEMOTHERAPY | HIV | EPOCH | Epstein-Barr virus | PATIENT | HEMATOLOGY | Doxorubicin - therapeutic use | Lymphoma, AIDS-Related - therapy | Prognosis | Humans | Lymphoma, AIDS-Related - pathology | Middle Aged | Male | Cyclophosphamide - therapeutic use | Plasmablastic Lymphoma - pathology | Lymphoma, AIDS-Related - diagnosis | Young Adult | Herpesvirus 4, Human - isolation & purification | Adult | Female | Plasmablastic Lymphoma - diagnosis | Lymphoma, AIDS-Related - virology | Anti-Retroviral Agents - therapeutic use | Hematopoietic Stem Cell Transplantation | Treatment Outcome | CD4 Lymphocyte Count | HIV - isolation & purification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Epstein-Barr Virus Infections - complications | Plasmablastic Lymphoma - therapy | Plasmablastic Lymphoma - virology | Prednisone - therapeutic use | Highly active antiretroviral therapy | Transplantation | Lymphomas | Hematopoietic stem cells
CD4 | Medicine & Public Health | Hematology | Combination antiretroviral therapy | Acquired immunodeficiency syndrome | Oncology | Plasmablastic lymphoma | Human immunodeficiency virus | Epstein–Barr virus | ORAL-CAVITY | AIDS | BORTEZOMIB | COMBINATION | CANCER | CHEMOTHERAPY | HIV | EPOCH | Epstein-Barr virus | PATIENT | HEMATOLOGY | Doxorubicin - therapeutic use | Lymphoma, AIDS-Related - therapy | Prognosis | Humans | Lymphoma, AIDS-Related - pathology | Middle Aged | Male | Cyclophosphamide - therapeutic use | Plasmablastic Lymphoma - pathology | Lymphoma, AIDS-Related - diagnosis | Young Adult | Herpesvirus 4, Human - isolation & purification | Adult | Female | Plasmablastic Lymphoma - diagnosis | Lymphoma, AIDS-Related - virology | Anti-Retroviral Agents - therapeutic use | Hematopoietic Stem Cell Transplantation | Treatment Outcome | CD4 Lymphocyte Count | HIV - isolation & purification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Epstein-Barr Virus Infections - complications | Plasmablastic Lymphoma - therapy | Plasmablastic Lymphoma - virology | Prednisone - therapeutic use | Highly active antiretroviral therapy | Transplantation | Lymphomas | Hematopoietic stem cells
Journal Article
Cell, ISSN 0092-8674, 10/2018, Volume 175, Issue 2, pp. 558 - 570.e11
Given that genomic DNA exerts its function by being transcribed, it is critical for the maintenance of homeostasis that DNA damage, such as double-strand...
Rad52 | transcription-associated homologous recombination repair | non-homologous end-joining | R-loop | DNA-RNA hybrid | genomic instability | DNA double-strand break | XPG | PATHWAY CHOICE | STRAND BREAK REPAIR | REPLICATION FORKS | LANDSCAPE | DNA-DAMAGE RESPONSE | HUMAN-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ATM | GENOME STABILITY | BRCA1 | NUCLEOTIDE EXCISION-REPAIR | CELL BIOLOGY | Cell Line | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Humans | Homologous Recombination | Nuclear Proteins - metabolism | Endonucleases - metabolism | DNA Breaks, Double-Stranded | Rad52 DNA Repair and Recombination Protein - genetics | RNA - genetics | DNA - genetics | DNA-Binding Proteins - metabolism | Transcription Factors - metabolism | Rad52 DNA Repair and Recombination Protein - metabolism | DNA End-Joining Repair | DNA Repair | Recombinational DNA Repair - physiology | Nuclear Proteins - physiology | DNA Damage | Nuclear Proteins - genetics | Endonucleases - physiology | Biotechnology | Medical colleges | RNA | DNA damage | Genes | Genetic transcription | DNA repair | Cells
Rad52 | transcription-associated homologous recombination repair | non-homologous end-joining | R-loop | DNA-RNA hybrid | genomic instability | DNA double-strand break | XPG | PATHWAY CHOICE | STRAND BREAK REPAIR | REPLICATION FORKS | LANDSCAPE | DNA-DAMAGE RESPONSE | HUMAN-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ATM | GENOME STABILITY | BRCA1 | NUCLEOTIDE EXCISION-REPAIR | CELL BIOLOGY | Cell Line | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Humans | Homologous Recombination | Nuclear Proteins - metabolism | Endonucleases - metabolism | DNA Breaks, Double-Stranded | Rad52 DNA Repair and Recombination Protein - genetics | RNA - genetics | DNA - genetics | DNA-Binding Proteins - metabolism | Transcription Factors - metabolism | Rad52 DNA Repair and Recombination Protein - metabolism | DNA End-Joining Repair | DNA Repair | Recombinational DNA Repair - physiology | Nuclear Proteins - physiology | DNA Damage | Nuclear Proteins - genetics | Endonucleases - physiology | Biotechnology | Medical colleges | RNA | DNA damage | Genes | Genetic transcription | DNA repair | Cells
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 02/2017, Volume 18, Issue 2, pp. 261 - 261
Wisteria floribunda agglutinin (WFA) preferably binds to LacdiNAc glycans, and its reactivity is associated with tumor progression. The aim of this study to...
Wisteria floribunda agglutinin (WFA) lectin | Biomarker | LacdiNAc | N-glycan | Prostate-specific antigen | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUCOSYLATED HAPTOGLOBIN | RADICAL PROSTATECTOMY | OVARIAN-CANCER | biomarker | HUMAN BREAST-CANCER | CHEMISTRY, MULTIDISCIPLINARY | GLYCOBIOMARKER | ACTIVE SURVEILLANCE | RECURRENCE | CARCINOMA | EXPRESSION | prostate-specific antigen | Immunohistochemistry | Multivariate Analysis | Prostatic Hyperplasia - pathology | Prognosis | Area Under Curve | Humans | Middle Aged | Male | Prostate - surgery | Prostatic Neoplasms - diagnosis | Receptors, N-Acetylglucosamine - metabolism | Neoplasm Recurrence, Local - pathology | Prostate - pathology | Neoplasm Grading | Aged, 80 and over | Prostatic Neoplasms - blood | Adult | Prostate-Specific Antigen - metabolism | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Risk Factors | Glycosylation | Prostate-Specific Antigen - blood | Polysaccharides - metabolism | Biomarkers, Tumor - blood | Biopsy | Prostatectomy | Prostatic Hyperplasia - blood | ROC Curve | Aged | Plant Lectins - metabolism | Antigens | Immunoassay | Hyperplasia | Benign | Hazards | Regression analysis | Multivariate analysis | Patients | Glycan | Polysaccharides | Reactivity | Quality | Biomarkers | Diagnostic systems | Tomatoes | Prostate | Prostate cancer | Cancer
Wisteria floribunda agglutinin (WFA) lectin | Biomarker | LacdiNAc | N-glycan | Prostate-specific antigen | BIOCHEMISTRY & MOLECULAR BIOLOGY | FUCOSYLATED HAPTOGLOBIN | RADICAL PROSTATECTOMY | OVARIAN-CANCER | biomarker | HUMAN BREAST-CANCER | CHEMISTRY, MULTIDISCIPLINARY | GLYCOBIOMARKER | ACTIVE SURVEILLANCE | RECURRENCE | CARCINOMA | EXPRESSION | prostate-specific antigen | Immunohistochemistry | Multivariate Analysis | Prostatic Hyperplasia - pathology | Prognosis | Area Under Curve | Humans | Middle Aged | Male | Prostate - surgery | Prostatic Neoplasms - diagnosis | Receptors, N-Acetylglucosamine - metabolism | Neoplasm Recurrence, Local - pathology | Prostate - pathology | Neoplasm Grading | Aged, 80 and over | Prostatic Neoplasms - blood | Adult | Prostate-Specific Antigen - metabolism | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Risk Factors | Glycosylation | Prostate-Specific Antigen - blood | Polysaccharides - metabolism | Biomarkers, Tumor - blood | Biopsy | Prostatectomy | Prostatic Hyperplasia - blood | ROC Curve | Aged | Plant Lectins - metabolism | Antigens | Immunoassay | Hyperplasia | Benign | Hazards | Regression analysis | Multivariate analysis | Patients | Glycan | Polysaccharides | Reactivity | Quality | Biomarkers | Diagnostic systems | Tomatoes | Prostate | Prostate cancer | Cancer
Journal Article
10.
Full Text
Upper critical fields of the 11-system iron-chalcogenide superconductor FeSeo.25Teo.75
Journal of the Physical Society of Japan, ISSN 0031-9015, 11/2009, Volume 78, Issue 11
Journal Article
Scientific Reports, ISSN 2045-2322, 01/2017, Volume 7, Issue 1, p. 40588
In cancer therapy today, carbon ion radiotherapy is used mainly as monotherapy, whereas cisplatin is used concomitantly with X-ray radiotherapy. The...
LUNG-CANCER | IN-VITRO | MULTIDISCIPLINARY SCIENCES | CERVICAL-CARCINOMA | TUMOR-CELLS | RADIOTHERAPY | REPLICATION STRESS | RADIATION | GLIOBLASTOMA CELLS | CHEMOTHERAPY | CANCER CELL-LINES | Mitosis - drug effects | Mitosis - radiation effects | Heavy Ion Radiotherapy | Apoptosis - drug effects | Apoptosis - radiation effects | X-Rays | Humans | Cell Line, Tumor | Clone Cells | Cisplatin - pharmacology | Ionizing radiation | Senescence | X rays | Cell death | Ions | Tumor cell lines | 4',6-Diamidino-2-phenylindole | Radiation therapy | Carbon | Cisplatin | Apoptosis | Cancer
LUNG-CANCER | IN-VITRO | MULTIDISCIPLINARY SCIENCES | CERVICAL-CARCINOMA | TUMOR-CELLS | RADIOTHERAPY | REPLICATION STRESS | RADIATION | GLIOBLASTOMA CELLS | CHEMOTHERAPY | CANCER CELL-LINES | Mitosis - drug effects | Mitosis - radiation effects | Heavy Ion Radiotherapy | Apoptosis - drug effects | Apoptosis - radiation effects | X-Rays | Humans | Cell Line, Tumor | Clone Cells | Cisplatin - pharmacology | Ionizing radiation | Senescence | X rays | Cell death | Ions | Tumor cell lines | 4',6-Diamidino-2-phenylindole | Radiation therapy | Carbon | Cisplatin | Apoptosis | Cancer
Journal Article
Circulation Journal, ISSN 1346-9843, 2016, Volume 80, Issue 3, pp. 668 - 676
Background:Elevated heart rate (HR) is an independent risk factor for cardiovascular outcomes in various cardiac diseases, including heart failure (HF).Methods...
Resting heart rate | Chronic heart failure | If inhibitor | Double-blind placebo-controlled trial | Left ventricular ejection fraction | inhibitor | RATE REDUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | EFFICACY | SAFETY | CARVEDILOL | DISEASE | OUTCOMES | LIFE | Dose-Response Relationship, Drug | Heart Rate - drug effects | Double-Blind Method | Humans | Middle Aged | Heart Failure - physiopathology | Female | Male | Aged | Benzazepines - pharmacology | Chronic Disease | Heart Failure - drug therapy
Resting heart rate | Chronic heart failure | If inhibitor | Double-blind placebo-controlled trial | Left ventricular ejection fraction | inhibitor | RATE REDUCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | EFFICACY | SAFETY | CARVEDILOL | DISEASE | OUTCOMES | LIFE | Dose-Response Relationship, Drug | Heart Rate - drug effects | Double-Blind Method | Humans | Middle Aged | Heart Failure - physiopathology | Female | Male | Aged | Benzazepines - pharmacology | Chronic Disease | Heart Failure - drug therapy
Journal Article
13.
Full Text
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Cancer, ISSN 0008-543X, 03/2012, Volume 118, Issue 6, pp. 1599 - 1606
BACKGROUND: Enhancer of zeste homolog 2 (EZH2) epigenetically silences many genes through the trimethylation of histone H3 lysine 27 and is implicated in tumor...
tumor size | prognostic biomarker | tumor progression | nonsmall cell lung cancer | tumor invasion | EZH2 | HISTONE METHYLTRANSFERASE ACTIVITY | PROMOTER HYPERMETHYLATION | DEVELOPMENTAL REGULATORS | DNA METHYLATION | E-CADHERIN | SOMATIC MUTATIONS | BREAST-CANCER | ONCOLOGY | EMBRYONIC STEM-CELLS | PROSTATE-CANCER | GROUP PROTEIN EZH2 | Carcinoma, Non-Small-Cell Lung - pathology | Immunohistochemistry | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Carcinoma, Non-Small-Cell Lung - chemistry | Prognosis | Lung Neoplasms - chemistry | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Humans | Middle Aged | Proportional Hazards Models | RNA, Messenger - analysis | DNA-Binding Proteins - analysis | Lung Neoplasms - pathology | Male | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Enhancer of Zeste Homolog 2 Protein | Polycomb Repressive Complex 2 | Cell Line, Tumor | Female | Aged | Transcription Factors - analysis | Research | Biological markers | Lung cancer, Non-small cell
tumor size | prognostic biomarker | tumor progression | nonsmall cell lung cancer | tumor invasion | EZH2 | HISTONE METHYLTRANSFERASE ACTIVITY | PROMOTER HYPERMETHYLATION | DEVELOPMENTAL REGULATORS | DNA METHYLATION | E-CADHERIN | SOMATIC MUTATIONS | BREAST-CANCER | ONCOLOGY | EMBRYONIC STEM-CELLS | PROSTATE-CANCER | GROUP PROTEIN EZH2 | Carcinoma, Non-Small-Cell Lung - pathology | Immunohistochemistry | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Carcinoma, Non-Small-Cell Lung - chemistry | Prognosis | Lung Neoplasms - chemistry | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Humans | Middle Aged | Proportional Hazards Models | RNA, Messenger - analysis | DNA-Binding Proteins - analysis | Lung Neoplasms - pathology | Male | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Enhancer of Zeste Homolog 2 Protein | Polycomb Repressive Complex 2 | Cell Line, Tumor | Female | Aged | Transcription Factors - analysis | Research | Biological markers | Lung cancer, Non-small cell
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_6
Abstract Background We have determined the recommended dose of weekly cetuximab (cet) plus SOX (oxaliplatin 130mg/m2 on day 1 and S-1 40 mg/m2 twice daily on...
Journal Article
Journal of the Physical Society of Japan, ISSN 0031-9015, 07/2010, Volume 79, Issue 7
Journal Article